🚀 VC round data is live in beta, check it out!
Emami Valuation Multiples
Discover revenue and EBITDA valuation multiples for Emami and similar public comparables like Shenzhen KTC Technology, Coty, Qingdao Baheal Medical, Blue Moon Group and more.
Emami Overview
About Emami
Emami Ltd is a fast-moving consumer goods company engaged in the manufacturing and marketing of personal care & healthcare products.. The company's portfolio includes trusted power brands like Navratna, BoroPlus, Fair & Handsome, Zandu Balm, Mentho Plus, and Kesh King. Geographically, the company generates the majority of its revenue from India.
Founded
1983
HQ
Employees
3.2K
Website
Financials (LTM)
EV
$2B
Emami Financials
Emami reported last 12-month revenue of $420M and EBITDA of $110M.
In the same LTM period, Emami generated $290M in gross profit, $110M in EBITDA, and $91M in net income.
Revenue (LTM)
Emami P&L
In the most recent fiscal year, Emami reported revenue of $445M and EBITDA of $120M.
Emami expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $420M | XXX | $445M | XXX | XXX | XXX |
| Gross Profit | $290M | XXX | $275M | XXX | XXX | XXX |
| Gross Margin | 69% | XXX | 62% | XXX | XXX | XXX |
| EBITDA | $110M | XXX | $120M | XXX | XXX | XXX |
| EBITDA Margin | 26% | XXX | 27% | XXX | XXX | XXX |
| EBIT Margin | 23% | XXX | 23% | XXX | XXX | XXX |
| Net Profit | $91M | XXX | $98M | XXX | XXX | XXX |
| Net Margin | 22% | XXX | 22% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Emami Stock Performance
Emami has current market cap of $2B, and enterprise value of $2B.
Market Cap Evolution
Emami's stock price is $4.88.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $2B | 0.5% | XXX | XXX | XXX | $0.22 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialEmami Valuation Multiples
Emami trades at 4.9x EV/Revenue multiple, and 18.5x EV/EBITDA.
EV / Revenue (LTM)
Emami Financial Valuation Multiples
As of April 20, 2026, Emami has market cap of $2B and EV of $2B.
Equity research analysts estimate Emami's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Emami has a P/E ratio of 23.5x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV/Revenue | 4.9x | XXX | 4.6x | XXX | XXX | XXX |
| EV/EBITDA | 18.5x | XXX | 17.0x | XXX | XXX | XXX |
| EV/EBIT | 21.5x | XXX | 19.5x | XXX | XXX | XXX |
| EV/Gross Profit | 7.0x | XXX | 7.4x | XXX | XXX | XXX |
| P/E | 23.5x | XXX | 21.8x | XXX | XXX | XXX |
| EV/FCF | 23.8x | XXX | 22.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Emami Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Emami Margins & Growth Rates
Emami's revenue in the last 12 month grew by 8%.
Emami's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.
Emami's rule of 40 is 34% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Emami's rule of X is 44% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Emami Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 8% | XXX | (6%) | XXX | XXX | XXX |
| EBITDA Margin | 26% | XXX | 27% | XXX | XXX | XXX |
| EBITDA Growth | 10% | XXX | (8%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 34% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 44% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 19% | XXX | 19% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 1% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 41% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Emami Public Comps
See public comps and valuation multiples for other Health & Beauty and Consumer Electronics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Emami | XXX | XXX | XXX | XXX | XXX | XXX |
| Shenzhen KTC Technology | XXX | XXX | XXX | XXX | XXX | XXX |
| Coty | XXX | XXX | XXX | XXX | XXX | XXX |
| Qingdao Baheal Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Blue Moon Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Flyco | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Emami M&A Activity
Emami acquired XXX companies to date.
Last acquisition by Emami was on XXXXXXXX, XXXXX. Emami acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Emami
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialEmami Investment Activity
Emami invested in XXX companies to date.
Emami made its latest investment on XXXXXXXX, XXXXX. Emami invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Emami
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Emami
| When was Emami founded? | Emami was founded in 1983. |
| Where is Emami headquartered? | Emami is headquartered in India. |
| How many employees does Emami have? | As of today, Emami has over 3K employees. |
| Is Emami publicly listed? | Yes, Emami is a public company listed on National Stock Exchange of India. |
| What is the stock symbol of Emami? | Emami trades under EMAMILTD ticker. |
| When did Emami go public? | Emami went public in 2006. |
| Who are competitors of Emami? | Emami main competitors are Shenzhen KTC Technology, Coty, Qingdao Baheal Medical, Blue Moon Group. |
| What is the current market cap of Emami? | Emami's current market cap is $2B. |
| What is the current revenue of Emami? | Emami's last 12 months revenue is $420M. |
| What is the current revenue growth of Emami? | Emami revenue growth (NTM/LTM) is 8%. |
| What is the current EV/Revenue multiple of Emami? | Current revenue multiple of Emami is 4.9x. |
| Is Emami profitable? | Yes, Emami is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Emami? | Emami's last 12 months EBITDA is $110M. |
| What is Emami's EBITDA margin? | Emami's last 12 months EBITDA margin is 26%. |
| What is the current EV/EBITDA multiple of Emami? | Current EBITDA multiple of Emami is 18.5x. |
| What is the current FCF of Emami? | Emami's last 12 months FCF is $86M. |
| What is Emami's FCF margin? | Emami's last 12 months FCF margin is 20%. |
| What is the current EV/FCF multiple of Emami? | Current FCF multiple of Emami is 23.8x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.